Matches in Nanopublications for { ?s ?p "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP753645.RAbbIUQIjtsgmrewkf2-HnaJFhjjZQa8qOVLpjBAfUqU0130_assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753645.RAbbIUQIjtsgmrewkf2-HnaJFhjjZQa8qOVLpjBAfUqU0130_provenance.
- assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_provenance.
- assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412015.RApdBlBNJlrVFNCCZ_ojPZrdy15QCfSuxfsxdSs1JPby0130_provenance.
- NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_provenance.
- NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_provenance.
- NP869792.RAljfpzCG9pIvx4fIlkq9KYSnxpbJCFPikDe_oHq8XIUs130_assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869792.RAljfpzCG9pIvx4fIlkq9KYSnxpbJCFPikDe_oHq8XIUs130_provenance.
- NP411806.RA28rs20XKWEGsPO4AHwzXGbpEVmvzOtFCgzLgl2lG6Ys130_assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411806.RA28rs20XKWEGsPO4AHwzXGbpEVmvzOtFCgzLgl2lG6Ys130_provenance.
- NP869787.RAPwjCSdW6-domhnhoV3Zy9pclaS87nc9d9iT6AWKnfjQ130_assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869787.RAPwjCSdW6-domhnhoV3Zy9pclaS87nc9d9iT6AWKnfjQ130_provenance.